Back

Risk of atrial tachycardias after covid-19: nationwide self-controlled cases series and matched cohort study.

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Risks and effects of interventions on prognosis and outcome in atrial fibrillation Prevalence and Incidence of Atrial Fibrillation ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Ioannis Katsoularis

Umea University Hospital, Umea (Sweden)

5 More presentations in this session

Presentation thumbnail
Risk of incident atrial fibrillation and subsequent use of oral anticoagulants in patients with dementia
Doctor T. Chao (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Oral anticoagulant use and outcomes in Asian patients with atrial fibrillation in the GLORIA-AF Registry
Doctor G. Romiti (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Amiodarone is associated with increased mortality compared with other antiarrhythmic drugs in female patients with atrial fibrillation
Professor J. Choi (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
AF in the AFternoon: The circadian pattern of incident atrial fibrillation in a loop recorder population
Doctor P. Chousou (Cambridge, GB)
Abstract Slides Video
Presentation thumbnail
Associations of adding salt to foods with incident atrial fibrillation in the UK biobank study
Doctor Y. Park (Daegu, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Risks and effects of interventions on prognosis and outcome in atrial fibrillation

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources